quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:08:39·986d
INSIDERFiling
Chinook Therapeutics Inc. logo

SEC Form 4: Greenman William Mariner returned 23,643 shares to the company, closing all direct ownership in the company

KDNY· Chinook Therapeutics Inc.
Health Care
Original source

Companies

  • KDNY
    Chinook Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Aug 8UpdateWedbush$42.00
  • Mar 6UpdatePiper Sandler$41.00
  • Mar 1UpdateGuggenheim$43.00
  • Dec 5UpdateWells Fargo$30.00
  • Jun 28UpdateStifel$30.00

Related

  • 13D/G883d
    SEC Form SC 13D/A filed by Chinook Therapeutics Inc. (Amendment)
  • SEC976d
    SEC Form 15-12G filed by Chinook Therapeutics Inc.
  • SEC981d
    SEC Form EFFECT filed by Chinook Therapeutics Inc.
  • 13D/G986d
    SEC Form SC 13D filed by Chinook Therapeutics Inc.
  • SEC986d
    SEC Form S-8 POS filed by Chinook Therapeutics Inc.
  • SEC986d
    SEC Form S-8 POS filed by Chinook Therapeutics Inc.
  • SEC986d
    SEC Form S-8 POS filed by Chinook Therapeutics Inc.
  • SEC986d
    SEC Form S-8 POS filed by Chinook Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022